Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

Pfizer

11 posts
RRoche
Roche, ViiV and Horizon most reputable pharmas: patient groups
Read More

Roche, ViiV and Horizon most reputable pharmas: patient groups

  • 2026-08-20
PatientView’s annual pharma reputation report, as scored by global patient groups, ranked Roche, ViiV Healthcare and Horizon Therapeutics as the…
RRoche
Citi Bullish on Innovent Biologics' Dual-Engine Strategy, Names It Top Biotech Pick — BigGo Finance
Read More

Citi Bullish on Innovent Biologics’ Dual-Engine Strategy, Names It Top Biotech Pick — BigGo Finance

  • 2026-08-07
Innovent Biologics (01801.HK) received strong endorsements from foreign brokerages after announcing its operating data for the first half…
NNovartis
Zacks Investment Ideas feature highlights: IBB, Novartis, Pfizer and Eli Lilly's
Read More

Zacks Investment Ideas feature highlights: IBB, Novartis, Pfizer and Eli Lilly’s

  • 2026-06-24
For Immediate Release Chicago, IL – June 24, 2026 – Today, Zacks Investment Ideas feature highlights iShares Biotechnology…
NNovartis
Zacks Investment Ideas feature highlights: IBB, Novartis, Pfizer and Eli Lilly's
Read More

Zacks Investment Ideas feature highlights: IBB, Novartis, Pfizer and Eli Lilly’s

  • 2026-06-24
For Immediate Release Chicago, IL – June 24, 2026 – Today, Zacks Investment Ideas feature highlights iShares Biotechnology…
RRoche
Sanofi becomes latest pharma to hold fire on UK R&D
Read More

Sanofi becomes latest pharma to hold fire on UK R&D

  • 2026-06-16
Sanofi has become the latest Big Pharma to freeze R&D investment decisions in the U.K., while Roche confirmed…
RRoche
Top pharmaceutical companies for innovation: Roche, AbbVie, Novartis, and more
Read More

Top pharmaceutical companies for innovation: Roche, AbbVie, Novartis, and more

  • 2026-06-09
The 2020 Pharmaceutical Invention and Innovation Indices, compiled by IDEA Pharma, were generated prior to the unfolding COVID-19…
RRoche
Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study
Read More

Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study

  • 2026-05-30
Roche Holding shares fell after the company said a late-stage study for an experimental breast-cancer treatment missed its…
RRoche
Swiss pharma companies likely to follow Pfizer-US price deal, business lobby says, ETPharma
Read More

Swiss pharma companies likely to follow Pfizer-US price deal, business lobby says, ETPharma

  • 2026-03-23
Geneva: Swiss pharma companies are likely to follow Pfizer‘s price deal with the U.S. following President Donald Trump‘s…
RRoche
Roche shares fall after breast cancer drug fails trial
Read More

Roche shares fall after breast cancer drug fails trial

  • 2026-03-09
 Shares in Roche dropped more than 5% on March 9 after the Swiss pharmaceutical company announced that its…
RRoche
Swiss pharma companies eye follow up to Pfizer-US pricing deal, business lobby says
Read More

Swiss pharma companies eye follow up to Pfizer-US pricing deal, business lobby says

  • 2026-03-01
By Olivia Le Poidevin and Cecile Mantovani GENEVA (Reuters) -Swiss drugmakers could strike their own deals with the…
RRoche
What Does It Signal for 2026?
Read More

What Does It Signal for 2026?

  • 2026-02-17
After a muted start to 2025, Big Pharma is back on the M&A trail. In just a month,…
Switzerland
www.europesays.com